Physician profile
Sean Hu
NPI 1336644376
$817.32
in general payments reported to CMS, 2019-2025
11 companies · $390 in 2025
The $390 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $118 · 2024: $309 · 2025: $390.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $817.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $817.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $145.90 | 2024 | Wegovy, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $144.22 | 2024 | Tezspire, Fasenra |
| Inspire Medical Systems, INC. | $126.10 | 2025 | Inspire |
| United Therapeutics Corporation | $121.84 | 2025 | Tyvaso |
| Boehringer Ingelheim Pharmaceuticals, INC. | $118.39 | 2023 | |
| Electromed, INC. | $44.59 | 2025 | Smartvest |
| Scpharmaceuticals INC. | $27.49 | 2025 | |
| Exact Sciences Corporation | $25.32 | 2025 | Cologuard Collection Kit |
| Verona Pharma, INC. | $23.79 | 2025 | Ohtuvayre |
| Insmed, INC. | $21.19 | 2025 | Brinsupri, Arikayce |
| Chiesi USA, INC. | $18.49 | 2024 | Cleviprex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean Hu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.